Table 1.
Demographics
P+H+ | P−H+ | P+H− | P−H− | P | |
---|---|---|---|---|---|
N | 16 | 17 | 16 | 18 | |
SCID-I Diagnosis (count) | Schizoaffective disorder (9); Schizophrenia (7); past MDE (on sx onset; 3); cannabis use d/o (in remission, 4); alcohol use d/o (in remission, 4); | None (12); Past MDE (4); cannabis use disorder (in remission, 2); alcohol use disorder (in remission, 1); | Schizophrenia (9); schizoaffective disorder (7); cannabis use disorder (in remission, 3); alcohol use disorder (in remission, 3); cocaine use disorder (in remission, 3) | None (15); past MDE (2); alcohol use disorder (in remission, 1) | |
Age (y) | 42.31±13.76 | 46.8235±12.47 | 37.75±13.78 | 39.67±12.98 | Hall: .075 Psych: .32 Interaction: 0.69 |
Sex | 43.75% (7) Male; 56.25% (9) Female | 23.5294% (4) Male; 76.4706% (13) Female | 56.25% (9) Male; 43.75% (7) Female | 44.4444% (8) Male; 55.5556% (10) Female | .29 |
Race | 68.75% (11) White, 18.75% (3) Black, 6.25% (1) Other | 82.3529% (14) White, 11.7647% (2) Black, 5.8824% (1) Other | 56.25% (9) White, 43.75% (7) Black, | 61.1111% (11) White, 33.3333% (6) Black, 5.5556% (1) Other | .21 |
Years of education | 14.125±1.9958 | 15.1765±2.2146 | 14.6±2.8486 | 14.8333±2.2816 | .63 |
Currently working | 25% | 82.3529% | 31.25% | 77.7778% | .00036 |
Full-scale IQ (from WRAT3) | 99.13±4.53 | 98.69±4.36 | 98.67±4.22 | 103.41±3.17 | Hall: .60 Psych: .60 Interaction: .53 |
Antipsychotic burden (CPZ equiv mgs) | 446.27±110.37 | 401.63±91.91 | .758678 |
Note: SCID-I, Structured Clinical Interview for DSM-4 Axis I Disorders; CPZ equivs, chlorpromazine equivalents (mgs); WRAT3, Wide-Range Achievement Test, 3rd edition; MDE, major depressive episode. Boldface represents significant values after correction for multiple comparisons.